Our study directly demonstrates that high expression of DHFR due to genomic alterations (HSR and ecDNA, especially ecDNA) is the major driving force behind MTX resistance in cancer cells, whereas previous reports on the important role of ecDNA in tumor evolution have mostly lacked direct evidence. This evidence concerns the gene DHFR and cancer.